Detalhe da pesquisa
1.
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.
J Hepatol
; 78(2): 343-355, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36309131
2.
Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone.
Front Pharmacol
; 15: 1378371, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38659594
3.
Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
Cell Biosci
; 13(1): 72, 2023 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37041570
4.
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.
Sci Transl Med
; 14(676): eabj4221, 2022 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36542691
5.
Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype.
Cancer Manag Res
; 11: 1337-1348, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30863148
6.
PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration.
Cancer Lett
; 385: 97-107, 2017 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-27816489